DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.65 (2019) >

Please use this identifier to cite or link to this item: http://ir.fmu.ac.jp/dspace/handle/123456789/1057

Files in This Item:

File Description SizeFormat
FksmJMedSci_65_p122.pdf177.83 kBAdobe PDFDownload
Title: Investigation of thyroid cancer cases that were not detected in the Thyroid Ultrasound Examination program of the Fukushima Health Management Survey but diagnosed at Fukushima Medical University Hospital
Authors: Yokoya, Susumu
Iwadate, Manabu
Shimura, Hiroki
Suzuki, Satoru
Matsuzuka, Takashi
Suzuki, Satoshi
Murono, Shigeyuki
Yasumura, Seiji
Kamiya, Kenji
Hashimoto, Yuko
Suzuki, Shin-Ichi
Affiliation: 甲状腺・内分泌診療センター
Source title: Fukushima Journal of Medical Science
Volume: 65
Issue: 3
Start page: 122
End page: 127
Issue Date: 2019
Abstract: The Great East Japan Earthquake, which occurred on March 11, 2011, and its subsequent Fukushima Daiichi Nuclear Power Plant accident, prompted implementation of the Thyroid Ultrasound Examination (TUE) program as a part of the Fukushima Health Management Survey. The purpose of this program is to support residents of Fukushima Prefecture, and to analyze the health effects of the released radionuclides. Regardless of relatively high participation rates and a well-planned diagnostic flow, it is conceivable that not all thyroid cancer cases can be detected by the TUE program. The aims of the present study were to identify and characterize these "outside" cases, targeting patients at Fukushima Medical University (FMU) Hospital. As of June 30, 2017, we have successfully identified 11 outside cases. These corresponded to 5.7% of the 194 subjects who were identified as having thyroid cancer or suspected thyroid cancer in the TUE program. Although the outside subjects of other institutes were not investigated, the present study may have identified the majority of outside subjects in Japan, considering that FMU Hospital treats a large number of thyroid cancer subjects. Furthermore, the characteristics of the 11 subjects were not different from those of the subjects identified in the TUE program. These findings confirm that the TUE program was able to identify subjects of thyroid cancer adequately and sufficiently.
Publisher: The Fukushima Society of Medical Science
Publisher (Alternative foam): 福島医学会
language: eng
URI: http://ir.fmu.ac.jp/dspace/handle/123456789/1057
Full text URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/1057/1/FksmJMedSci_65_p122.pdf
ISSN: 0016-2590
DOI: 10.5387/fms.2019-26
PubMed ID: 31839647
Related Page: https://doi.org/10.5387/fms.2019-26
Rights: © 2019 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
Rights: https://creativecommons.org/licenses/by-nc-sa/4.0/
Appears in Collections:Vol.65 (2019)

Files in This Item:

File Description SizeFormat
FksmJMedSci_65_p122.pdf177.83 kBAdobe PDFDownload

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard